U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07206615) titled 'Spot Ex PMCF 01 Study' on Sept. 26.

Brief Summary: Post market clinical study that is a chart review of the Spot Ex Endoscopic Marker

Study Start Date: Oct., 2025

Study Type: OBSERVATIONAL

Condition: Presence of Spot Ex Endoscopic Marker

Intervention: OTHER: Endoscopic marker

Study to confirm the safety and performance of the Laborie Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Laborie Medical Technologies Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....